R Leblay
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Hematology 10
- Multiple Myeloma Research and Treatments 5
- Genetics 8
- Chronic Lymphocytic Leukemia Research 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Co-authors
- R Fauchet (4 shared papers)Olivier Fardel (2 shared papers)P. Y. Leprise (2 shared papers)J Chaperon (3 shared papers)J Goasguen (3 shared papers)G. Tertian (2 shared papers)M Leporrier (1 shared paper)Karim Maloum (1 shared paper)
- Journals
- Blood (2 papers)Journal of Clinical Oncology (1 paper)British journal of surgery (1 paper)New England Journal of Medicine (1 paper)Cancer (1 paper)
- Partner nations
- FranceSwitzerlandTunisia
In The Last Decade
R Leblay
30 papers receiving 809 citations
Peers
Comparison fields: 5 of 57
- Genetics 365
- Hematology 206
- Pathology and Forensic Medicine 227
- Oncology 283
- Immunology 131
Countries citing papers authored by R Leblay
This map shows the geographic impact of R Leblay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Leblay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Leblay more than expected).
Fields of papers citing papers by R Leblay
This network shows the impact of papers produced by R Leblay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Leblay. The network helps show where R Leblay may publish in the future.
Co-authors
The 25 scholars most cited alongside R Leblay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 324 | |
| 2 | 1993 | 192 | |
| 3 | 1993 | 157 | |
| 4 | 1991 | 44 | |
| 5 | 1993 | 23 | |
| 6 | 1997 | 18 | |
| 7 | 1986 | 13 | |
| 8 | 1985 | 12 | |
| 9 | 2007 | 8 | |
| 10 | 1997 | 7 | |
| 11 | 2000 | 4 | |
| 12 | [Secondary paraneoplastic polycythemia of testicular cancer]. | 1989 | 4 |
| 13 | 1988 | 3 | |
| 14 | 1985 | 3 | |
| 15 | 1998 | 2 | |
| 16 | [Renal lesions in myelofibrosis (author's transl)]. | 1980 | 2 |
| 17 | 2002 | 2 | |
| 18 | 1987 | 2 | |
| 19 | [Diagnostic splenectomy. Apropos of 38 cases]. | 1990 | 2 |
| 20 | Maladie de Hodgkin: étude de l'hypersensibilité retardée de 64 malades non traités. Intérêt du test épicutané à l'huile de croton | 1977 | 1 |
About R Leblay
R Leblay is a scholar working on Hematology, Genetics, Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases, having authored 31 papers that have together received 833 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Abdominal Trauma and Injuries (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Viral Infections and Vectors (2 papers). The work is most often cited by research in Genetics (365 citations), Hematology (206 citations), Pathology and Forensic Medicine (227 citations), Oncology (283 citations) and Immunology (131 citations). R Leblay has collaborated with scholars based in France, Switzerland and Tunisia. Frequent co-authors include R Fauchet, Olivier Fardel, P. Y. Leprise, J Chaperon, J Goasguen, G. Tertian, M Leporrier, Karim Maloum, Maurice Navarro and Philippe Travade. Their work appears in journals such as Blood, Journal of Clinical Oncology, British journal of surgery, New England Journal of Medicine and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.